Patents by Inventor Sorge Kelm

Sorge Kelm has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • LIGAND-CONJUGATES AND METHODS FOR TARGETED RECEPTOR-MEDIATED CELLULAR UPTAKE
    Publication number: 20200254110
    Abstract: Provided are ligand-conjugates and methods for targeted receptor-mediated cellular uptake of an entity of interest of desired activity and function.
    Type: Application
    Filed: September 25, 2018
    Publication date: August 13, 2020
    Inventors: Ursula MIRASTSCHIJSKI, Mario WAESPY, Sørge KELM
  • Siglec inhibitors
    Patent number: 7820714
    Abstract: The invention relates to Siglec inhibitors that have an increased affinity for the receptor molecule. The Siglec inhibitors provided by the invention are preferably selective of a given Siglec molecule. The invention further relates to a method for producing Siglec inhibitors and to a method for increasing the binding selectivity for a given Siglec molecule. The invention also relates to pharmaceutical compositions that contain the Siglec inhibitors and to medical indications for the Siglec inhibitors.
    Type: Grant
    Filed: June 7, 2002
    Date of Patent: October 26, 2010
    Inventors: Sorge Kelm, Reinhard Brossmer
  • Peptide Mixture From Peptides Having A Molecular Weight Of from 1000 To 5000 Dalton
    Publication number: 20080096794
    Abstract: The invention relates to the use of a peptide mixture comprising peptides with a molecular weight from 1000 to 5000 Daltons for the prevention and/or treatment of tumour diseases, of diseases which are associated with a development disorder of the immune system, of diseases of the immune system, of autoimmune reactions, of allergies and of inflammation in man, a protein component which contains such a peptide mixture and a formula food containing this peptide mixture. The peptides are preferably obtained from non-human proteins suitable for nutritional purposes, in particular by the enzymatic or hydrolytic cleavage of these proteins.
    Type: Application
    Filed: August 12, 2005
    Publication date: April 24, 2008
    Inventors: Gunther Boehm, Christopher Beermann, Bernd Stahl, Gilda Georgi, Joachim Schmitt, Nadine Bock, Sorge Kelm
  • Sialic carbohydrates
    Publication number: 20050070464
    Abstract: The invention relates to the use of sialic carbohydrates of general formula (I), containing at least one carbohydrate unit of general formula (II) for the immune modulation, immune suppression and in the prevention and treatment of infections in humans and animals.
    Type: Application
    Filed: January 31, 2003
    Publication date: March 31, 2005
    Inventors: Bernd Stahl, Sorge Kelm, Gunther Boehm, Berndt Finke, Joachim Schmitt
  • Siglec inhibitors
    Publication number: 20040176309
    Abstract: The invention relates to Siglec inhibitors that have an increased affinity for the receptor molecule. The Siglec inhibitors provided by the invention are preferably selective of a given Siglec molecule. The invention further relates to a method for producing Siglec inhibitors and to a method for increasing the binding selectivity for a given Siglec molecule. The invention also relates to pharmaceutical compositions that contain the Siglec inhibitors and to medical indications for the Siglec inhibitors.
    Type: Application
    Filed: February 13, 2004
    Publication date: September 9, 2004
    Inventors: Sorge Kelm, Reinhard Brossmer
  • Compositions and methods for the identification and synthesis of sialyltransferases
    Patent number: 5962294
    Abstract: DNA isolates coding for sialyltransferase which contain a conserved region of homology and methods of obtaining such DNA are provided, together with expression systems for recombinant production of sialyltransferase.
    Type: Grant
    Filed: August 4, 1993
    Date of Patent: October 5, 1999
    Assignees: The Regents of the University of California, Amgen, Inc.
    Inventors: James C. Paulson, Xiaohong Wen, Brian Livingston, William Gillespie, Sorge Kelm, Alma L. Burlingame, Katalin Medzihradszky
  • Compositions and methods for producing sialyltransferases
    Patent number: 5858751
    Abstract: DNA isolates coding for sialyltransferase which contain a conserved region of homology and methods of obtaining such DNA are provided, together with expression systems for recombinant production of the various sialyltransferases.
    Type: Grant
    Filed: July 12, 1995
    Date of Patent: January 12, 1999
    Assignee: The Regents of the University of California
    Inventors: James C. Paulson, Xiaohong Wen, Brian Livingston, Alma L. Burlingame, Katalin Medzihradszky, Sorge Kelm, William Gillespie